融合成像辅助超声引导热消融预防邻近胆管肝脏恶性肿瘤主要胆道并发症的初步对照研究
单中心回顾性研究纳入289例患者共316个邻近胆管的肝脏恶性肿瘤,比较融合成像(FI)辅助与非FI辅助超声引导热消融的安全性和疗效。FI组主要胆道并发症发生率为1.6%,显著低于非FI组的7.9%(p=0.005),而技术有效率(99.5% vs 98.4%,p=0.56)和局部进展率(3.8% vs 5.7%,p=0.61)无显著差异。提示FI辅助热消融可降低邻近胆管肝脏肿瘤的主要胆道并发症。
要点
- FI辅助超声引导热消融可显著降低邻近胆管肝脏肿瘤的主要胆道并发症(1.6% vs 7.9%)。
- FI不影响技术有效率(99.5% vs 98.4%)和局部肿瘤进展率(3.8% vs 5.7%)。
- 对邻近胆管的肝脏恶性肿瘤行热消融时,建议考虑使用融合成像辅助。
诊断标准与关键数值
- FI组消融后主要胆道并发症发生率为1.6%,非FI组为7.9%(p=0.005)。
- FI组技术有效率为99.5%(185/186),非FI组为98.4%(123/125)(p=0.56)。
- FI组局部肿瘤进展率为3.8%(7/185),非FI组为5.7%(7/123)(p=0.61)。
临床应用与阅片要点
- 对邻近胆管的肝脏恶性肿瘤行超声引导热消融时,可考虑使用融合成像辅助以降低主要胆道并发症风险。
- 术后1个月采用增强CT/MR评估技术疗效,并每3-6个月随访胆道并发症和局部肿瘤进展。
局限性
- 回顾性单中心研究,FI组与非FI组的分组非随机,选择偏倚可能存在。
- 样本量有限,为初步对照研究。
- 试验仅回顾性注册。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Ultrasound (US)-guided thermal ablation (TA) may cause major biliary complications, particularly in patients with malignant liver tumors (MLTs) adjacent to the bile ducts. Fusion imaging (FI), is postulated to reduce complication rate; however, there is a lack of clinical data to support this theory. Thus, the aim of our study was to evaluate the safety and efficacy of FI for TA of MLTs proximal to the bile ducts.
METHODS: A retrospective single-center review was conducted on a total of 289 patients with 316 MLTs adjacent to the bile ducts. The patients were divided into two groups based on whether FI was used in the ablation procedures. The choice of the FI-assisted procedure always depends on different operation periods and whether registrations will succeed. The baseline demographics and outcomes of these patients were compared. The efficacy was determined at the 1-month follow-up using contrast-enhanced computed tomography/magnetic resonance. Biliary complications and local tumor progression were subsequently followed-up every 3-6 months. The last follow-up visit was before August 30, 2019.
RESULTS: Among the included tumors, the incidence rate of major biliary complications after ablation in the FI group was 1.6%, which was significantly lower than that in the non-FI group (7.9%, p = 0.005). There was no significant difference in the efficacy rates of the techniques [99.5% (185/186) versus 98.4% (123/125), p = 0.56] or local progression rates [3.8% (7/185) versus 5.7% (7/123), p = 0.61] between the FI and non-FI groups.
CONCLUSION: FI for US-guided TA could be a noninvasive means to decrease major biliary complications. Trial registration number and date of registration: retrospectively registered.
引用
- Liu, Li, Zeng, et al. Prevention of major biliary complications by fusion imaging for thermal ablation of malignant liver tumors adjacent to the bile ducts: a preliminary comparative study. Abdom Radiol (NY). 2022. PMID: 36121457. doi:10.1007/s00261-022-03631-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。